WebDr Fonarow is on the steering committee for the American Heart Association's Get with the Guidelines (GWTG) program, ADHERE Registries, and OPTIMIZE-HF. He serves as a … WebBoback Ziaeian 1 2 , Gregg C Fonarow 1 3 Affiliations 1Division of Cardiology, David Geffen School of Medicine at UCLA, 10833 Le Conte Avenue, Los Angeles, California 90095, USA.
Medical Therapy for Heart Failure With Reduced Ejection
WebJul 24, 2024 · Electronic address: [email protected]. PMID: 30025570 DOI: 10.1016/j.jacc.2024.04.070 Abstract Background: Guidelines strongly recommend patients with heart failure with reduced ejection fraction (HFrEF) be treated with multiple medications proven to improve clinical outcomes, as tolerated. WebFeb 1, 2024 · Bassi NS, Ziaeian B, Yancy CW, Fonarow GC. Association of optimal implementation of sodium–glucose cotransporter 2 inhibitor therapy with outcome for patients with heart failure. JAMA Cardiol 2024;5:1–5. [ Europe PMC free article] [ Abstract] [ Google Scholar] jared washington san jose
Gregg C. Fonarow, MD Cardiology - Los Angeles, CA
WebApr 19, 2024 · Kumbhani DJ, Fonarow GC, Heidenreich PA, Schulte PJ, Lu D, Hernandez A, Yancy C, Bhatt DL. Association between hospital volume, processes of care, and outcomes in patients admitted with heart failure: … WebJun 1, 2024 · Bassi NS, Ziaeian B, Yancy CW, Fonarow GC. Association of optimal implementation of sodium-glucose cotransporter 2 inhibitor therapy with outcome for … WebDec 25, 2012 · Gregg Fonarow MD. @gcfmd. ·. Mar 8. The risk reduction of the primary outcome was consistent across subgroups of age, sex, education, antihypertensive medication use, and baseline CV risk … low gi food singapore